Indication intelligence, analysis and sector perception

Henry McCusker

Henry McCusker
Chairman of RegMed Investors <RMi>

Henry enters his 11th year, as an analyst and publisher who curates content of RegMed, stem, gene and cell therapy sector's news and "events" in order to provide an original and relevant investment thesis.

Henry's mission is to provide readers with coverage, intelligence and metrics to define the sector's ever changing sentiment and perception.

Henry was Founder of Scimitar Equity, a sell-side analysis firm after being a SVP - Strategic Planning and Communication at Curis from 2000 through 2001. Henry worked with H&QCM (now Tekla Capital Management) beginning in 1985 through 2000, where he focused on healthcare investments. He also concurrently founded LifeScience Economics; a research and analytics firm with offices in Boston, MA and Palo Alto, CA. Additional past work experiences include Thermo Scientific and SWEC following 5 years at the FBI.

A former military officer, Henry has been an adjunct professor at both Boston University and Golden Gate University where he taught courses in venture capital, corporate finance and strategic development at the universities' graduate business schools.

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

8 hours 40 min ago
RegMed Investors’ (RMi) pre-open: market, market and the sector pullbacks are driven by Israel retaliation against Iran tempered expectations for a rate cut

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.

Indication intelligence, analysis and sector perception

Henry McCusker

Henry McCusker Chairman of RegMed Investors <RMi>

What's Happening Today

Henry McCusker
Chairman of RegMed Investors <RMi>